For the Inventor, By the Inventor

Enter assignee name

Seattle, WA, United States of America

Rarecyte, Inc.

USPTO Granted Patents = 60

CIPO Patents = 1

EPO Patents = 6

Trademarks = 18

Forward Citations = 169

Loading Chart...

Loading Chart...

22 inventors (with patents filed for the assignee):

Steve Quarre (32 out of 32 patents)

Ronald C Seubert (23 out of 24 patents)

Daniel E Campton (23 out of 23 patents)

4. Joshua Nordberg (22 out of 22 patents)

5. David Edward Stewart (19 out of 25 patents)

6. Lance U'Ren (17 out of 17 patents)

7. Jonathan Lundt (9 out of 9 patents)

8. Jennifer Chow (9 out of 9 patents)

9. Edward Shafer (8 out of 8 patents)

10. Arturo Bernardo Ramirez (8 out of 9 patents)

11. Jeremy Cooper (5 out of 12 patents)

12. Joel Smith (4 out of 4 patents)

13. Jackie Stilwell (4 out of 4 patents)

14. Paulina Varshavskaya (3 out of 3 patents)

15. Melinda R Duplessis (3 out of 3 patents)

Core Competencies:

Spectral Crosstalk

Fluorescence Imaging

Optical Trains

Spectral Edge Detection

Automated Substrate Loading

Analyte Detection

Biomarker Labeling

Antigen-Specific Immune Cells

Fluid Dispersion

Target Material Collection

Target Analyte Selection

Suspension Analysis

60 patents: Sort by Forward Citations

1. 12222487 - Holding a substrate within a secondary device (2025-02-11),

2. 12038381 - Methods of reducing spectral crosstalk in multiplexed fluorescence imaging (2024-07-16),

3. 11719929 - Optical trains for imaging systems and spectral edge detection (2023-08-08),

4. 11692939 - Spectral edge detection (2023-07-04),

5. 11573415 - Device, system, and method for changing angle of incidence of a filter or filter wheel (2023-02-07),

6. 11422352 - Automated substrate loading (2022-08-23),

7. 11402301 - Device, system, and method for selecting a target analyte (2022-08-02),

8. 11300769 - Automated substrate loading (2022-04-12),

9. 11237377 - Apparatus for holding a substrate within a secondary device (2022-02-01),

10. 11231344 - Device, system, and method for selecting a target analyte (2022-01-25),

11. 11119106 - Analyte detection (2021-09-14),

12. 11105803 - Method to identify antigen-specific immune cells (2021-08-31),

13. 11067487 - Apparatus, system, and method for collecting a target material (2021-07-20),

14. 11054346 - Detecting a substrate (2021-07-06),

15. 10962362 - Detecting a substrate (2021-03-30),

RareCyte, Inc. is a biotech company dedicated to providing innovative liquid biopsy solutions for cancer research and diagnostics. They specialize in the development and commercialization of technologies that enable the detection and analysis of rare cells circulating in the bloodstream. With their cutting-edge CTC technology, RareCyte aims to revolutionize cancer diagnostics and personalized medicine.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Jan 13 2026

60 Patents

#36 in Seattle, WA

#108 in Washington

#5,827 in US

#11,805 in the World

Seattle, WA, United States of America

Rarecyte, Inc.

Forward Citations = 169

22 inventors:

Steve Quarre (32 out of 32 patents)

Ronald C Seubert (23 out of 24 patents)

Daniel E Campton (23 out of 23 patents)

4. Joshua Nordberg (22 out of 22 patents)

5. David Edward Stewart (19 out of 25 patents)

Please report any incorrect information to support@idiyas.com

Loading…